CR
Christopher Ryan Sullivan sold $202K of AVTX stock
Christopher Ryan Sullivan, Chief Financial Officer of Avalo Therapeutics, Inc. (AVTX), sold 12,394 shares of AVTX stock worth $202K, per an SEC Form 4 filed Sep 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 16, 2026, 2 days before it was made public.
AVTX has moved -55.5% since the trade date, from $16.58 to $7.37 (Nov 16, 2026 close).
- Traded
- Sep 16, 2026
- Disclosed
- Sep 18, 2026
- Filing delay
- 2 days
- Price since
- -55.5%
- Role
- Chief Financial Officer
- Source
- SEC Form 4